These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3164514)

  • 21. Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy.
    Steinkamp G; Lütge M; Wurster U; Schulz-Baldes JG; Gröne HJ; Ehrich JH
    Eur J Pediatr; 1986 Dec; 145(6):526-31. PubMed ID: 2880721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymuria in neonates receiving continuous intravenous infusion of gentamicin.
    Colding H; Brygge K; Brendstrup L; Bentzon MW; Andersen GE
    APMIS; 1992 Feb; 100(2):119-24. PubMed ID: 1348177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity of N-acetyl-beta-D-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies.
    Langhendries JP; Mattot M; François A; Deprez D; Battisti O; Bertrand JM; Schoos S
    Biol Neonate; 1989; 56(2):76-82. PubMed ID: 2790088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal papillary necrosis and urinary protein alterations induced in Fischer-344 rats by D-ormaplatin.
    Kolaja GJ; Packwood WH; Bell RR; Ratke CC; Stout CL
    Toxicol Pathol; 1994; 22(1):29-38. PubMed ID: 8073221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
    Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion.
    Wellwood JM; Lovell D; Thompson AE; Tighe JR
    J Pathol; 1976 Mar; 118(3):171-82. PubMed ID: 1263024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymuria as an index of renal damage in sheep with induced aminoglycoside nephrotoxicosis.
    Garry F; Chew DJ; Hoffsis GF
    Am J Vet Res; 1990 Mar; 51(3):428-32. PubMed ID: 1969254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: clinical significance and prognostic value of low molecular weight ("tubular") proteins.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Jan; 29(1):27-35. PubMed ID: 9002527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of the nephrotoxicity of amikacin in patients with cystic fibrosis].
    Hügli R; Artho G; Wiesmann UN; Peheim E; Schaad UB; Bianchetti MG
    Schweiz Med Wochenschr; 1992 Jun; 122(24):930-5. PubMed ID: 1377401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins and aminoglycoside nephrotoxicity.
    Assael BM; Chiabrando C; Gagliardi L; Noseda A; Bamonte F; Salmona M
    Toxicol Appl Pharmacol; 1985 May; 78(3):386-94. PubMed ID: 4049389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S; Plant ND; Spencer DA
    J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B; Ravnskov U
    Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary clusterin in chronic nephrotoxicity in the rat.
    Eti S; Cheng CY; Marshall A; Reidenberg MM
    Proc Soc Exp Biol Med; 1993 Apr; 202(4):487-90. PubMed ID: 8456116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic renal tubular effects in relation to urine cadmium levels.
    Mueller PW; Smith SJ; Steinberg KK; Thun MJ
    Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of D-penicillamine on glomerular basement membrane, urinary N-acetyl-beta-D-glucosaminidase and protein excretion in rats.
    Khalil-Manesh F; Price RG
    Toxicology; 1983; 26(3-4):325-34. PubMed ID: 6857704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Sairei-to on gentamicin nephrotoxicity in rats.
    Ohno I; Shibasaki T; Nakano H; Matsuda H; Matsumoto H; Misawa T; Ishimoto F; Sakai O
    Arch Toxicol; 1993; 67(2):145-7. PubMed ID: 8481103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.